1. Home
  2. BLCO vs IBP Comparison

BLCO vs IBP Comparison

Compare BLCO & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • IBP
  • Stock Information
  • Founded
  • BLCO 1853
  • IBP 1977
  • Country
  • BLCO Canada
  • IBP United States
  • Employees
  • BLCO N/A
  • IBP N/A
  • Industry
  • BLCO Ophthalmic Goods
  • IBP Homebuilding
  • Sector
  • BLCO Health Care
  • IBP Consumer Discretionary
  • Exchange
  • BLCO Nasdaq
  • IBP Nasdaq
  • Market Cap
  • BLCO 4.9B
  • IBP 4.5B
  • IPO Year
  • BLCO 2022
  • IBP 2014
  • Fundamental
  • Price
  • BLCO $13.72
  • IBP $190.62
  • Analyst Decision
  • BLCO Hold
  • IBP Buy
  • Analyst Count
  • BLCO 13
  • IBP 11
  • Target Price
  • BLCO $15.83
  • IBP $222.00
  • AVG Volume (30 Days)
  • BLCO 758.1K
  • IBP 424.4K
  • Earning Date
  • BLCO 07-30-2025
  • IBP 07-31-2025
  • Dividend Yield
  • BLCO N/A
  • IBP 1.60%
  • EPS Growth
  • BLCO N/A
  • IBP N/A
  • EPS
  • BLCO N/A
  • IBP 8.78
  • Revenue
  • BLCO $4,829,000,000.00
  • IBP $2,933,200,000.00
  • Revenue This Year
  • BLCO $6.97
  • IBP N/A
  • Revenue Next Year
  • BLCO $5.48
  • IBP $3.73
  • P/E Ratio
  • BLCO N/A
  • IBP $22.63
  • Revenue Growth
  • BLCO 11.94
  • IBP 4.30
  • 52 Week Low
  • BLCO $10.45
  • IBP $150.83
  • 52 Week High
  • BLCO $21.69
  • IBP $281.04
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 63.37
  • IBP 56.75
  • Support Level
  • BLCO $12.02
  • IBP $188.29
  • Resistance Level
  • BLCO $14.35
  • IBP $207.52
  • Average True Range (ATR)
  • BLCO 0.45
  • IBP 6.91
  • MACD
  • BLCO 0.06
  • IBP 0.51
  • Stochastic Oscillator
  • BLCO 72.96
  • IBP 48.56

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

Share on Social Networks: